triethylenemelamine has been researched along with Erythrocytosis in 1 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Urethane is the best treatment available for multiple myeloma." | 1.23 | New therapy for leukemia, polycythemia, and lymphoma. ( BARTLETT, GR; MARLOW, AA, 1953) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MARLOW, AA | 1 |
| BARTLETT, GR | 1 |
1 other study available for triethylenemelamine and Erythrocytosis
| Article | Year |
|---|---|
New therapy for leukemia, polycythemia, and lymphoma.
Topics: Aminopterin; Chronic Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Mechlorethamine; Multiple | 1953 |